Latest News on the Fertility Supplements Market (2026)
- In May 2026, Nature’s Bounty launched a fertility support supplement with NAC, CoQ10, selenium, and vitamins, enhancing egg quality and ovulation support, thereby increasing demand for science-backed fertility supplements and market growth.
- In September 2025, SwimClub launched a clinically formulated male fertility supplement targeting sperm count, motility, and DNA integrity, addressing global sperm decline and expanding the market growth.
- In July 2025, Carrot introduced Sprints metabolic-fertility program, integrating preconception care and hormonal support, reducing IVF cycles and driving preventive fertility supplement and wellness market growth.
Key Market Trends and Insights
- Based on ingredient source, the synthetic segment held around 89% in the historical period.
- By form, the capsule segment accounted for nearly 39% in the historical period.
- Based on the distribution channel, the over-the-counter segment captured approximately 77% market share in the historical period.
Market Size and Forecast
- Market Size (2025) : USD 2.45 Billion
- Projected Market Size (2035) : USD 5.44 Billion
- CAGR (2026-2035) : 8.30%
Fertility Supplements Market Overview
Fertility supplements are gaining significant attention due to increasing reproductive health concerns, changing lifestyles, and delayed parenthood among individuals worldwide. These supplements support nutritional balance and hormonal health, contributing to improved fertility management and wellness outcomes. The market was valued at USD 2.45 Billion in 2025 and is witnessing steady growth due to rising infertility prevalence and growing consumer awareness regarding reproductive nutrition. Increasing demand for natural ingredients, personalized formulations, and scientifically supported products is further supporting industry expansion. The growing adoption of preventive healthcare practices and advancements in fertility-focused dietary supplements are also contributing to long-term market development.Fertility Supplements Market Segmentation
Market Breakup by Product Type
- Herbal Supplements
- Vitamin-Based Supplements
- Mineral-Based Supplements
- Amino Acids and Antioxidants
- Probiotics
Market Breakup by Ingredient Source
- Natural
- Synthetic
Market Breakup by Form
- Capsules
- Tablets
- Gummies
- Powders
- Others
Market Breakup by Gender
- Men
- Women
Market Breakup by Distribution Channel
- Over-the-Counter
- Prescription-Based
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Fertility Supplements Market Growth Analysis and Key Influencers
Analysis Type
Factors
Example
Market Drivers
WHO reported infertility affects nearly 1 in 6 people of reproductive age worldwide, supporting supplement adoption.Market Restraints
High fertility treatment costs and inconsistent success rates reduce accessibility and limit spending on supportive fertility supplements.IVF treatment costs range between USD 3,000-25,000 globally, discouraging long-term fertility-related healthcare spending among consumers.
Market Opportunities
Advancements in prenatal and liposomal fertility supplements with improved absorption are expected to support market expansion.In May 2026, Solaray launched Liposomal Prenatal supplements containing methylfolate, iodine, choline, and liposomal iron ingredients.
Market Dynamics
The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.Fertility Supplements Market Growth Drivers
Increasing Infertility Concerns and Reproductive Health Awareness Supporting Market Expansion
The rising incidence of infertility, hormonal imbalances, stress-related reproductive disorders, and delayed pregnancies is increasing the demand for fertility supplements globally. Consumers are becoming more aware of the role of nutritional supplement in improving reproductive health and fertility outcomes. According to the World Health Organization (WHO), infertility affects approximately 1 in 6 people of reproductive age worldwide, demonstrating the growing burden of reproductive health issues. The increasing focus on preventive healthcare technologies and services, fertility wellness, and affordable supportive care solutions is expected to further accelerate the adoption of fertility supplements during the forecast period.Fertility Supplements Market Restraints
High Cost of Fertility Treatments and Uneven Success Rates Restrain Market Growth
The high cost of fertility treatments and varying success rates continue to limit the growth of the market, particularly in low- and middle-income countries. According to World Fertility Services, the average IVF treatment cost ranges from USD 3,000-6,000 in India, USD 6,000-9,000 in Thailand, and USD 15,000-25,000 in the United States, while success rates vary between 65% and 75%. These financial burdens and uncertain outcomes reduce treatment accessibility and discourage long-term spending on fertility-related supplements and supportive therapies.Fertility Supplements Market Opportunities
Advancements in Prenatal and Liposomal Fertility Supplements Can Support Market Expansion
The increasing development of advanced prenatal and fertility supplements with enhanced nutrient absorption and digestive comfort is expected to support market growth during the forecast period. For instance, in May 2026, Solaray launched its liposomal prenatal supplement designed for women before conception and during early pregnancy. The product includes liposomal iron, choline, iodine, and methylfolate for improved absorption and reduced digestive discomfort. Such innovations are anticipated to increase consumer preference for science-backed and personalized fertility nutrition products.Fertility Supplements Market Trends
The market is witnessing several trends, including male fertility nutrition and science-based supplement expansion.Rising Focus on Male Fertility Supplements is Likely to Enhance Market Growth
The increasing awareness regarding male reproductive health is encouraging the development of targeted fertility supplements with clinically backed ingredients. For instance, in April 2026, TIES launched a doctor-formulated men’s fertility supplement after securing USD 1.5 million in seed funding, highlighting growing industry focus on male preconception care and reproductive wellness. The rising availability of specialized male fertility products is expected to support long-term market growth.Increasing Expansion of Science-Driven Fertility Supplement Brands is Boosting the Fertility Supplements Market Value
The growing consumer preference for evidence-based and retail-accessible fertility solutions is accelerating investments in innovative supplement brands. For example, in August 2025, U.K.-based Ova raised USD 1 million in pre-seed funding to expand its fertility supplement portfolio and strengthen retail presence across major stores. The increasing commercialization of science-led reproductive health products is anticipated to contribute significantly to market expansion during the forecast period.Fertility Supplements Market Share
Women Segment Expected to Lead the Market Segmentation by Gender
The market is segmented by gender into men and women, addressing varying reproductive health needs and nutritional requirements. Women are expected to lead the segment due to rising cases of delayed pregnancies, increasing prevalence of infertility, and growing awareness of prenatal nutrition and hormonal balance support. Expanding consumption of folic acid, iron, and multivitamin-based fertility supplements further supports this dominance. Rising lifestyle-related fertility challenges continue to strengthen demand. Overall, the segment is anticipated to witness sustained expansion during the forecast period.Fertility Supplements Market Analysis by Region
The regions included in the report are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, with North America emerging as the leading region due to high infertility prevalence and strong healthcare awareness. The market is driven by increasing adoption of fertility supplements to support reproductive health. According to Liv Hospital, approximately 11% of women of childbearing age in the United States face infertility, while about 9% of men experience fertility issues. This rising burden is expected to sustain demand across the forecast period.Leading Players in the Fertility Supplements Market
Fairhaven Health, LLC
Fairhaven Health, LLC develops science-based fertility supplements supporting women and men across reproductive stages. Its product portfolio includes FH PRO fertility multivitamins for both partners, designed to enhance preconception health and hormonal balance. The company is actively involved in the market through practitioner-recommended, clean-label, and clinically studied formulations.Coast Science
Coast Science specializes in fertility and hormonal support supplements, widely used in preconception and IVF preparation. Its flagship formulations are designed to improve reproductive outcomes using evidence-based ingredients. The company is involved in the fertility supplements market with physician-trusted products and has reportedly supported over 500,000 patients globally through international clinical partnerships.Lenus Pharma GesmbH
Lenus Pharma GesmbH offers clinically tested fertility supplements including Profertil® for male and female reproductive health and PCOS management. Its product range is based on scientific research and focuses on improving fertility outcomes. The company participates in the market through evidence-based formulations and sustainable pharmaceutical production practices globally.ORTHOMOL Pharmazeutische Vertriebs GMBH
Orthomol Pharmazeutische Vertriebs GMBH provides fertility-focused micronutrient supplements such as Orthomol Natal pre and Orthomol Fertil plus for women and men. These formulations support reproductive health, cell division, and overall nutritional balance. The company is active in the fertility supplements market with clinically designed products for preconception and pregnancy support.Other key players in the market are Exeltis USA, Inc., Vitabiotics (India) Private Limited, Gonadosan Distribution GmbH (Fertilovit), Babystart Ltd., YAD-Tech Inc., and Crown Nutraceuticals (Crown Fertility).
Key Questions Answered in the Fertility Supplements Market Report
- What was the fertility supplements market value in 2025?
- What is the fertility supplements market forecast outlook for 2026-2035?
- What major factors aid the demand for the fertility supplements market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major fertility supplements market trends?
- Which product type is expected to dominate the market segment?
- Which ingredient source is projected to lead the market segment?
- Which form is anticipated to drive the market segment?
- Which gender is likely to dominate the market segment?
- Which distribution channel is expected to dominate the market segment?
- Who are the key players in the fertility supplements market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
Companies Mentioned
- Fairhaven Health, LLC
- Coast Science
- Lenus Pharma GesmbH
- ORTHOMOL Pharmazeutische Vertriebs GMBH

